PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Epidermal Growth Factor Receptor 24,772 Target Disease Carcinoma 433,099 4,400 0.04 -0.90 0.18 0.64
CD4 112,219 Target Drug Abacavir 1,496 276 0.02 -0.90 0.18 0.65
Epidermal Growth Factor Receptor 24,772 Target Disease Lung Cancer 91,416 3,773 0.08 -0.90 0.15 0.72
Epidermal Growth Factor Receptor 24,772 Target Disease Lung Cancer 91,416 3,773 0.08 -0.90 0.15 0.72
Epidermal Growth Factor Receptor 24,772 Target Disease Breast Cancer 173,695 4,150 0.06 -0.90 0.17 0.69
CXCL9 1,016 Target Target CCL3 1,427 117 0.10 -0.90 0.12 0.82
CXCL7 76 Target Target CCL5 2,002 14 0.04 -0.90 0.18 0.74
Calmodulin 25,240 Target Target CAMK2D 21 4 0.01 -0.90 0.19 0.64
BRK 236 Target Disease Breast Cancer 173,695 45 0.01 -0.90 0.19 0.61
ELC 355 Target Target DC-CK1 22 4 0.05 -0.90 0.18 0.77
Eotaxin-3/CCL26 26 Target Disease Asthma 109,610 5 0.00 -0.90 0.19 0.60
CCL7 274 Target Target CCL14 34 6 0.06 -0.90 0.18 0.80
BMP-7 1,112 Target Target Collagen 138,882 215 0.02 -0.90 0.19 0.64
Epidermal Growth Factor Receptor 24,772 Target Target Erbb2 4,536 770 0.07 -0.90 0.17 0.74
Histamine H4 Receptor 168 Target Disease Inflammation 252,734 33 0.01 -0.90 0.20 0.60
Alpha-2a Adrenergic Receptor 188 Target Target Alpha-2c Adrenergic Receptor 42 7 0.08 -0.90 0.17 0.82
BD3 32 Target Target BD4 26 3 0.10 -0.90 0.12 0.86
Epidermal Growth Factor Receptor 24,772 Target Target ERBB4 994 191 0.04 -0.90 0.19 0.70
EPHB4 329 Target Target EPHB3 118 18 0.09 -0.90 0.15 0.82
CCL3 1,427 Target Target CCL1 220 39 0.07 -0.89 0.18 0.78
D4-GDI 35 Target Disease Cancer 1,053,491 7 0.00 -0.89 0.20 0.55
Nad-Dependent Protein Deacetylase Sirtuin-1 5 Target Target Collagen 138,882 1 0.00 -0.89 0.20 0.59
Renin 43,456 Target Drug Avapro (Irbesartan)- FDA 5 1 0.00 -0.89 0.20 0.61
Angiotensin Converting Enzyme 31,674 Target Drug Avapro (Irbesartan)- FDA 5 1 0.00 -0.89 0.20 0.62
Calmodulin 25,240 Target Target Adp/Atp Translocase 1 5 1 0.00 -0.89 0.20 0.62
Collapsin Response Mediator Protein-1 30 Target Disease Lung Cancer 91,416 6 0.00 -0.89 0.20 0.61
ANXA7 35 Target Disease Prostate Cancer 71,064 7 0.00 -0.89 0.20 0.62
Ent2 108 Target Target Equilibrative Nucleoside Transporter 1 211 15 0.10 -0.89 0.14 0.84
Androgen Receptor 12,918 Target Target ADRBK1 10 2 0.01 -0.89 0.20 0.65
CCL2 3,560 Target Target Small Inducible Cytokine A2 5 1 0.01 -0.89 0.20 0.67
CCL5 2,002 Target Target Small Inducible Cytokine A2 5 1 0.01 -0.89 0.20 0.69
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target Glutathione S-Transferase A3 15 3 0.01 -0.89 0.20 0.67
Hiv-1 Integrase 1,199 Target Drug Kadsurarin 5 1 0.01 -0.89 0.20 0.70
CXCL7 76 Target Target CCL2 3,560 15 0.03 -0.89 0.20 0.72
Toll-Like Receptor 2 2,174 Target Disease Inflammation 252,734 434 0.02 -0.89 0.20 0.63
CCL14 34 Target Target CCL8 197 6 0.07 -0.89 0.18 0.81
Epidermal Growth Factor Receptor 24,772 Target Disease Non Small Cell Lung Cancer 28,563 2,827 0.11 -0.89 0.11 0.78
CD95 4,266 Target Target Apo I 55 11 0.02 -0.89 0.20 0.71
Annexin A1 406 Target Disease Inflammation 252,734 82 0.01 -0.89 0.20 0.61
CNTF 1,613 Target Target BDNF 11,163 292 0.07 -0.89 0.18 0.75
CCL7 274 Target Target CXCL10 2,386 51 0.06 -0.89 0.19 0.77
CD1A 2,739 Target Target CD4 112,219 547 0.03 -0.89 0.20 0.66
CD1A 2,739 Target Target CD14 9,941 456 0.09 -0.89 0.17 0.77
CCL4 5,638 Target Target CCL5 2,002 316 0.09 -0.89 0.16 0.79
Collagen 138,882 Target Target BMP-2 3,889 783 0.03 -0.89 0.20 0.66
4-1BB Receptor 20 Target Target CD137 474 4 0.04 -0.89 0.20 0.76
Cysteinyl Leukotriene Receptor 2 24 Target Disease Inflammation 252,734 5 0.00 -0.89 0.21 0.58
Mu Opioid Receptor 4,576 Target Drug Dpdpe 1,204 206 0.09 -0.89 0.17 0.79
ApoE4 1,525 Target Disease Cholesterol 182,390 316 0.02 -0.89 0.21 0.64
Macrophage Metalloelastase 100 Target Disease Inflammation 252,734 21 0.00 -0.89 0.21 0.60
Eotaxin-2/CCL24 19 Target Disease Asthma 109,610 4 0.00 -0.89 0.21 0.60
Endostatin 1,599 Target Target Collagen 138,882 339 0.02 -0.89 0.21 0.65
Glutathione Transferase Omega-1 14 Target Disease Breast Cancer 173,695 3 0.00 -0.89 0.21 0.59
CCL3 1,427 Target Target CCL8 197 38 0.07 -0.89 0.19 0.78
Cox-2 21,583 Target Disease Inflammation 252,734 4,343 0.06 -0.89 0.20 0.68
CCL7 274 Target Target CCL3 1,427 51 0.08 -0.89 0.19 0.79
CA 72-4 184 Target Target CA 15-3 898 34 0.08 -0.89 0.18 0.80
CXCL16 341 Target Disease Inflammation 252,734 74 0.01 -0.88 0.22 0.61
ERBB4 994 Target Target EGF 27,487 210 0.04 -0.88 0.21 0.70
ACVR1B 23 Target Target Activin A 2,048 5 0.02 -0.88 0.22 0.72
CXCL10/IP-10 114 Target Disease Inflammation 252,734 25 0.00 -0.88 0.22 0.60
Androgen Receptor 12,918 Target Drug Doxorubicin-Formaldehyde Conjugate 9 2 0.01 -0.88 0.22 0.65
CCL2 3,560 Target Target CXCL4/PF4 9 2 0.01 -0.88 0.22 0.68
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
BAFF 1,240 Target Target CD254 9 2 0.02 -0.88 0.22 0.72
CXCL9 1,016 Target Target CXCL4/PF4 9 2 0.02 -0.88 0.22 0.72
EGF 27,487 Target Target ERBB3 1,154 251 0.04 -0.88 0.22 0.71
CD1A 2,739 Target Target CD68 6,424 458 0.11 -0.88 0.17 0.80
CXCL11 526 Target Disease Inflammation 252,734 119 0.01 -0.88 0.23 0.61
Bile Salt Export Pump 476 Target Target Multidrug Resistance-Associated Protein 2 462 57 0.12 -0.88 0.12 0.85
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
Antithrombin 13,773 Target Drug Angiomax (Bivalirudin)- FDA 13 3 0.01 -0.88 0.23 0.65
Aurora B kinase 415 Target Disease Cancer 1,053,491 96 0.00 -0.88 0.23 0.57
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
CCL14 34 Target Disease Inflammation 252,734 8 0.00 -0.87 0.24 0.59
Crth2 Receptor 51 Target Disease Inflammation 252,734 12 0.00 -0.87 0.24 0.59
CCL3 1,427 Target Target CXCL2 750 123 0.12 -0.87 0.16 0.83
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Cancer 1,053,491 55 0.00 -0.87 0.24 0.57
CCL7 274 Target Target CCL5 2,002 60 0.08 -0.87 0.22 0.79
DAPK2 27 Target Target DAPK1 205 6 0.08 -0.87 0.22 0.81
CCL5 2,002 Target Target CCL8 197 45 0.07 -0.87 0.23 0.78
CXCL10 2,386 Target Disease Inflammation 252,734 585 0.02 -0.87 0.25 0.64
CCL5 2,002 Target Target CXCL10/IP-10 114 27 0.06 -0.87 0.24 0.76
CCL3 1,427 Target Target CXCL10 2,386 238 0.13 -0.87 0.17 0.83
ADRBK2 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
CD62L/L-Selectin 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Disease Inflammation 252,734 1 0.00 -0.87 0.25 0.58
Ck-beta-11 4 Target Disease Breast Cancer 173,695 1 0.00 -0.87 0.25 0.59
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Target Collagen 138,882 1 0.00 -0.87 0.25 0.59
Glutathione S-Transferase Mu 2 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Prostaglandin Reductase 1 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Xaa-Pro Dipeptidase 4 Target Target EGF 27,487 1 0.00 -0.87 0.25 0.62
Epidermal Growth Factor Receptor 24,772 Target Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.63
Ck-beta-11 4 Target Target CD34 24,598 1 0.00 -0.87 0.25 0.63
Antithrombin 13,773 Target Drug Alprostadil Injection (Caverject)- FDA 4 1 0.00 -0.87 0.25 0.64
Xaa-Pro Dipeptidase 4 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.87 0.25 0.64
CCL4 5,638 Target Target CCBL1 4 1 0.01 -0.87 0.25 0.66
EPHB3 118 Target Target EPHB1 137 17 0.13 -0.87 0.14 0.87
Estrogen Receptor Beta 1,924 Target Target Egl Nine Homolog 1 4 1 0.01 -0.87 0.25 0.69